🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In order to assess the potential impact of steady state BI 425809 on CYP3A ...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2022-03-18
Trial ID
NCT05258110
Treatments Being Tested
The main objective of this trial is to investigate the relative bioavailabi...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2019-02-11
Trial ID
NCT03817476
Treatments Being Tested
The primary objective of this trial is to investigate the absolute oral bio...
Status
Completed
Location
ICON
Start Date
2019-01-15
Trial ID
NCT03783000
Treatments Being Tested
The study is designed to compare the effects of BI 425809 compared to place...
Status
Completed
Location
Axiom Research LLC
Start Date
2016-08-11
Trial ID
NCT02788513
Treatments Being Tested
The primary objective of this trial is to investigate the relative bioavail...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2017-03-28
Trial ID
NCT03082183
Treatments Being Tested
The main objective of this trial is to investigate the relative bioavailabi...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2023-03-06
Trial ID
NCT05723874
The objective of the study is to investigate the efficacy, safety and pharm...
Status
Completed
Location
Collaborative Neuroscience Network, LLC (CNS)
Start Date
2016-07-25
Trial ID
NCT02832037
Treatments Being Tested
This study is open to adults with schizophrenia. Schizophrenia can affect t...
Status
Completed
Location
Clinical Innovations, Inc
Start Date
2021-08-24
Trial ID
NCT04846881
Treatments Being Tested
The main objective of this trial is to investigate the effect of fluconazol...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2021-10-19
Trial ID
NCT05076409
Treatments Being Tested
To investigate whether and to what extent co-administration of multiple dos...
Status
Completed
Location
1346.10.1 Boehringer Ingelheim Investigational Site
Start Date
2015-01
Trial ID
NCT02342717
Treatments Being Tested